Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Radiotherapy & Radiosurgery
Brachytherapy
What brachytherapy is, how high-dose rate (HDR) and low-dose rate (LDR) internal radiation target tumours while sparing healthy tissue, what the clinical evidence shows, how it compares with external radiation methods, approximate costs in Turkey compared with the UK, US and Germany, hospital stay requirements, recovery milestones, potential side effects and what to ask your oncology team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Radiotherapy & Radiosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Brachytherapy
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Brachytherapy in Turkey: what it is and how internal radiation works
Brachytherapy is an internal radiation therapy where a sealed radioactive source is placed directly inside or next to a tumour. Unlike external beam radiation, which passes through healthy skin and organs to reach deep targets, internal radiation delivers concentrated energy from within. Because radiation intensity drops rapidly with distance following the physical inverse-square law, the tumour receives a high therapeutic dose while adjacent normal tissues receive minimal exposure. Hospitals offering brachytherapy in Turkey use this approach for gynaecological, prostate, and breast cancers. For an overview of cancer services, see our guide to oncology treatments in Turkey.
What is brachytherapy designed to achieve? The primary goal is curative tumour control while sparing adjacent organs. This guide outlines how internal radiation works, clinical evidence, approximate costs vs the UK, US, and Germany, recovery milestones, and safety standards.
High-dose rate (HDR) versus low-dose rate (LDR) brachytherapy
Internal radiation is delivered primarily through two techniques: high-dose rate (HDR) and low-dose rate (LDR).
In high-dose rate (HDR) brachytherapy, an intense radioactive source—typically Iridium-192—is driven by a robotic remote afterloader through hollow catheters into the tumour. The source pauses at pre-calculated positions for seconds or minutes before retracting into a shielded safe. Delivery takes 10 to 20 minutes. Because no radioactive material remains in the body, patients emit zero radiation and can return to a ward or home immediately.
In low-dose rate (LDR) brachytherapy, tiny radioactive seeds (such as Iodine-125) are permanently implanted into the tumour—most commonly the prostate—using ultrasound-guided needles, gradually decaying until inert. Modern oncology centres increasingly favour automated HDR for its precise robotic control and outpatient convenience.
Does brachytherapy work and what does the clinical evidence show?
Yes. Decades of clinical registry data confirm that internal radiation delivers exceptional local tumour control. International guidelines from ESTRO, ASTRO, and the UK National Institute for Health and Care Excellence (NICE) endorse brachytherapy across multiple cancers.
So, does brachytherapy work reliably? In locally advanced cervical cancer, omitting brachytherapy substantially reduces survival; delivering a concentrated boost directly to the cervix while sparing the bladder is standard curative care. In localized prostate cancer, seed brachytherapy achieves 10- to 15-year disease-free survival exceeding 90%, matching radical surgery with lower incontinence rates.
However, brachytherapy cannot treat distant metastases. It requires clear anatomical access and is designed for localized tumours or combined multi-modality programmes.
Brachytherapy cost in Turkey compared with the UK, US and Germany
The total brachytherapy price depends on the tumour site, whether treatment involves permanent LDR seeds or fractionated HDR sessions, applicator complexity, and hospital stay duration. The table below outlines approximate comparative costs.
| Country | Approximate cost range |
|---|---|
| Turkey | €4,000 – €9,500 |
| United Kingdom | €9,000 – €22,000 |
| United States | €15,000 – €38,000 |
| Germany | €8,500 – €20,000 |
When assessing brachytherapy cost quotes, note that hospital packages in Turkey typically include CT or MRI simulation, physicist dosimetry planning, applicator placement under anaesthesia, radiation sessions, nursing care, and transfers. Additional expenses may apply if concurrent external radiotherapy or specialized interstitial needles are required.
How brachytherapy compares with external beam radiation and stereotactic radiosurgery
Radiation oncology employs several modalities depending on tumour volume, depth, and anatomical constraints.
| Modality | Best suited to | Typical limits |
|---|---|---|
| High-Dose Rate (HDR) Brachytherapy | Cervical, uterine, breast, and select prostate tumours; temporary source placement | Requires applicator insertion under anaesthesia; repeated outpatient or brief inpatient sessions |
| Low-Dose Rate (LDR) Brachytherapy | Organ-confined, low-to-intermediate risk prostate cancer; permanent radioactive seeds | Not suited for bulky extra-capsular extension or significant urinary obstruction |
| External Beam Radiotherapy (EBRT) | Locally advanced tumours, involved regional lymph nodes, or non-invasive delivery | Irradiates a larger volume of surrounding normal tissue over 4–7 weeks of daily sessions |
When treating large volumes or draining lymph nodes, external irradiation is necessary. Clinicians often use advanced techniques like tomotherapy for rotational beam delivery. In contrast, for non-invasive treatment of localized brain tumours or intracranial metastases, specialists utilise stereotactic gamma knife radiosurgery. In many gynaecological protocols, external therapy is administered first to sterilize pelvic nodes, followed by brachytherapy to boost the central tumour.
Who is a good candidate for brachytherapy, and who is not?
Good candidates have histologically confirmed, localized malignancies in accessible sites. For prostate cancer, ideal candidates have organ-confined disease (T1c–T2a), PSA under 10–15 ng/mL, and minimal baseline urinary symptoms. In gynaecology, candidates include women undergoing definitive chemoradiotherapy for cervical cancer or post-hysterectomy vaginal cuff radiation. Selected low-risk breast cancer patients may also qualify after lumpectomy.
Patients not suited include those with distant metastases, uncorrected bleeding disorders, active pelvic infections, or anatomy precluding safe applicator placement. Severe urinary obstruction or very large prostate glands require alternative approaches or prior hormonal therapy. A multidisciplinary tumour board evaluates each case before treatment is scheduled.
The brachytherapy procedure step by step: anaesthesia, placement and delivery
A typical brachytherapy procedure follows five structured steps:
1. Anaesthesia and insertion: Under spinal, general, or local sedation, the radiation oncologist places hollow needles, catheters, or applicators directly into or around the tumour using ultrasound, CT, or visual guidance.
2. 3D imaging simulation: CT or MRI scans are acquired with applicators in place to verify the exact spatial geometry of the tumour and neighbouring organs (rectum, bladder, and bowel).
3. Treatment planning: A medical physicist uses computerized dosimetry software to calculate source dwell times down to fractions of a millimetre, maximizing tumour coverage while sparing healthy tissue.
4. Automated radiation delivery: In a shielded bunker, the robotic afterloader drives the Iridium-192 source through each catheter, delivering radiation over 10 to 20 minutes without sensation.
5. Applicator removal: Once the source retracts safely into the machine, applicators are removed, light dressings applied, and the patient rests in recovery.
Brachytherapy before and after: what do follow-up scans show?
Unlike cosmetic procedures evaluated by visual photographs, brachytherapy before and after results are measured through diagnostic imaging, histological margins, and laboratory tumour markers. Post-treatment MRI, CT, or PET scans do not show immediate changes; rather, they demonstrate gradual tumour shrinkage, resolution of active tumour vascularity, or fibrosis over several months.
For prostate cancer, clinical success is confirmed by tracking a steady decline in prostate-specific antigen (PSA) levels over 12 to 24 months toward a low nadir. In cervical cancer, follow-up examinations and MRI scans confirm local regression and healthy tissue healing. Scans show biological tumour inactivation rather than instantaneous disappearance. Patients follow scheduled imaging check-ups at 3, 6, and 12 months.
Treatment trip timeline and brachytherapy recovery
Patients travelling for brachytherapy Turkey treatment typically stay 5 to 10 days. A single-session LDR seed implant or a multi-fraction HDR schedule can usually be completed within a week, allowing time for consultations, simulation, treatment delivery, and post-procedure checks.
During early brachytherapy recovery, mild soreness, swelling, and minor spotting or pinkish urine are normal. For prostate patients, a urinary catheter is removed within 24 hours. Over the first 2 to 4 weeks, mild urinary frequency or transient bowel looseness may occur, manageable with simple medications. Most individuals return to light desk work within 5 to 7 days and resume routine exercise within 2 to 3 weeks. Long-term tumour control is monitored through scheduled follow-up scans and tumour markers coordinated with your local doctor.
Potential side effects and safety considerations
Because internal radiation concentrates energy within the tumour, systemic side effects like hair loss and severe nausea do not occur. However, localized tissues can experience temporary inflammation. Guidance from ASTRO and the NHS divides side effects into acute and late categories.
Acute effects include temporary fatigue, urinary frequency, dysuria, rectal irritation, or vaginal tenderness, typically resolving within 4 to 8 weeks. Less common late effects may include chronic radiation proctitis, cystitis, urethral stricture, or sexual dysfunction; modern 3D image guidance greatly reduces these risks.
Regarding safety: HDR brachytherapy leaves no radioactive material in your body after treatment, posing zero risk to others. With permanent LDR prostate seeds, low-energy radiation is absorbed within the gland, though clinicians advise avoiding prolonged lap contact with infants or pregnant women for two months.
How to choose an oncology centre in Turkey and questions to ask
Choose a hospital with an accredited radiation oncology department, modern 3D image-guided afterloaders, certified medical physicists, and a multidisciplinary tumour board. Red flags include clinics that quote prices without reviewing pathology or scans, promise guaranteed cures, or fail to provide complete digital dosimetry plans for your home oncologist.
To understand the coordination process before travelling, read how our process works. You can submit your medical files for evaluation through our free quote page. Essential questions to ask your clinical team:
- Which brachytherapy technique (HDR or LDR) do you recommend for my case, and why?
- Will my treatment plan be calculated using 3D MRI or CT guidance?
- How many brachytherapy procedures does your team perform annually?
- Will a multidisciplinary tumour board review my diagnostics before treatment?
- What acute and late side effects should I anticipate, and what support is provided?
- Will I receive full digital dosimetry files and treatment records for my home doctor?
Hospitals with Oncology in Turkey
Frequently asked questions
Brachytherapy is an internal radiation therapy where a sealed radioactive source is placed directly inside or next to a tumour. It delivers high radiation doses to cancerous tissue while sparing nearby healthy organs. It is commonly used for gynaecological, prostate, and breast cancers, either as a standalone curative treatment or combined with external beam radiation.
Yes. Clinical trials and international oncology guidelines confirm high success rates. In cervical cancer, brachytherapy is an essential curative component that substantially improves survival. For early prostate cancer, permanent seed brachytherapy achieves 10- to 15-year disease-free survival rates above 90 per cent, matching results from radical surgery with a lower risk of urinary incontinence.
Approximate costs in Turkey range from €4,000 to €9,500, compared with €9,000 to €22,000 in the UK and up to €38,000 in the US. The price varies depending on tumour type, whether LDR seeds or HDR fractions are used, and whether external radiation or chemotherapy is needed. Hospitals confirm exact prices after reviewing medical records.
In cancer treatment, results are measured through imaging and tumour markers rather than cosmetic photographs. Post-treatment MRI, CT, or PET scans demonstrate tumour shrinkage or complete disappearance over several months. For prostate cancer, regular blood tests track a steady decline in PSA levels, confirming that active malignant cells have been successfully neutralized.
Immediate recovery takes a few days. Catheters are removed within 24 hours, and mild soreness settles quickly. Temporary urinary frequency or bowel looseness can last two to four weeks. Most patients return to desk work within five to seven days and resume full physical activities within two to three weeks, guided by clinical advice.
Applicator or needle insertion is performed under spinal, general, or local anaesthesia, so you feel no pain during placement. Delivering the radiation itself takes 10 to 20 minutes and is completely painless. Afterwards, patients often experience mild pelvic soreness, tenderness, or temporary burning during urination, which is easily managed with prescribed pain relief.
Radiation damage to cancer cell DNA is permanent, preventing malignant cells from dividing and causing them to die. When used as a curative treatment for localized disease, long-term remission rates exceed 80 to 90 per cent. Ongoing follow-up imaging and clinical evaluations confirm sustained tumour control over subsequent years.
With high-dose rate (HDR) brachytherapy, the radioactive source is removed entirely after each session, meaning you emit zero radiation and pose no risk to others. With permanent low-dose rate (LDR) prostate seeds, low radiation is contained within the organ; patients simply avoid prolonged close contact with pregnant women or young children for two months.
External beam radiation directs beams through healthy skin and organs over several weeks, making it ideal for large tumours or regional lymph nodes. Brachytherapy places radiation directly inside the tumour over fewer sessions, delivering higher targeted doses with less exposure to adjacent organs. Many treatment protocols combine both modalities for maximum curative effect.
Most international patients need to stay in Turkey for 5 to 10 days. This duration provides enough time for initial medical consultations, baseline imaging simulation, treatment planning, applicator insertion, radiation delivery sessions, and essential post-treatment safety evaluations before returning home.
Patient stories